1887

Chapter 23 : Biosafety Compliance: a Global Perspective

Authors: Richard Rebar, Halley Moriyama
Content Type: Reference
Publication Year: 2006

Category: Clinical Microbiology; Applied and Industrial Microbiology

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Preview Magnify
Zoom in
Zoomout

Biosafety Compliance: a Global Perspective, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815899/9781555813390_Chap23-1.gif /docserver/preview/fulltext/10.1128/9781555815899/9781555813390_Chap23-2.gif

Abstract:

This chapter provides an overview of the regulations and guidelines for handling biohazards and recombinant DNA (rDNA) in workplaces around the world. The Genetic Manipulation Advisory Committee (GMAC) oversees the development and use of innovative genetic manipulation techniques in Australia so that risks to the safety of workers or potential hazards to the community or environment associated with the genetics of manipulated organisms are identified and can be managed. Most biosafety issues are addressed at the provincial level under transportation of dangerous goods legislation, occupational health and safety legislation, general public health and safety legislation, and federal and provincial Workplace Hazardous Materials Information System (WHMIS) legislation. A bill must be passed by both the U.S. House of Representatives and the U.S. Senate before it becomes a Public Law. The International Civil Aviation Organization (ICAO) has developed regulations for the safe transport of dangerous goods by air. These regulations have been incorporated by the International Air Transport Association’s (IATA) into a set of internationally accepted regulations which cover the packaging and transportation of dangerous goods (including infectious materials) internationally.

Citation: Rebar R, Moriyama H. 2006. Biosafety Compliance: a Global Perspective, p 417-436. In Fleming D, Hunt D (ed), Biological Safety. ASM Press, Washington, DC. doi: 10.1128/9781555815899.ch23

Key Concept Ranking

Hepatitis B Vaccine
0.5192308
Risk Assessment
0.4678125
0.5192308
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555815899.ch23
1. Centers for Disease Control and Prevention and National Institutes of Health. 1999. Biosafety in Microbiological and Biomedical Laboratories, 4th ed. U.S. Government Printing Office, Washington, D.C.
2. Centers for Disease Control and Prevention and National Institutes of Health. 2000. Primary Containment for Biohazards: Selection, Installation and Use of Biological Safety Cabinets, 2nd ed. J. Y. Richmond and R. W. McKinney (ed.). U.S. Government Printing Office, Washington, D.C. [Available on line at http://www.cdc.gov/od/ohs/pdffiles/BSC-3.pdf.]
3. Commission of the European Communities. 2000. Directive 2000/54/EC of the European Parliament and of the Council of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work (seventh individual directive within the meaning of Article 16 (1) of Directive 89/391/EEC. EN Document Official Journal of the European Communities L262/21-65,17.10.2000.
4. Health and Safety Commission. 1992. Workplace Health, Safety and Welfare, L24. Approved Codes of Practice. ISBN 0 11 886333 9.
5. Health and Safety Commission. 1992. Personal Protective Equipment at Work. Regulations. Guidance on Regulations, L25. ISBN 0 7176 6139 3.
6. Health and Safety Commission. 1999. Management of Health and Safety at Work. Approved Codes of Practice. ISBN 0 11 886330 4.
7. Health and Safety Commission. 2002. Control of Substances Hazardous to Health and Control of Carcinogenic Substances and Control of Biological Agents, L5. Approved Codes of Practice. ISBN 0 7176 0819 0.
8. Health and Safety Executive Advisory Committee on Dangerous Pathogens. 1990. Categorisation of Pathogens According to Hazard and Categories of Containment, 2nd ed. ISBN 0 11 885564 6.
9. Health and Safety Executive Advisory Committee on Dangerous Pathogens and Advisory Committee on Genetic Modifications. 1990. Vaccination of Laboratory Workers Handling Vaccinia and Related Poxviruses Infectious for Humans. ISBN 0 11 885450 X.
10. National Institutes of Health. 2002. Guidelines for research involving recombinant DNA molecules (NIH guidelines). Fed. Regist. 66:57970. (April 2002 and subsequent amendments available at http://www4.od. nih.gov/oba.)
11. National Research Council. 1989. Biosafety in the Laboratory: Prudent Biosafety Practices for the Handling and Disposal of Infectious Materials. National Academy Press, Washington, D.C.
12. Occupational Safety and Benefit Authority of Chemical Industry. Safe Biotechnology: Laboratories—Equipment and Standard Practices. Guidelines M 056e 3/89.
13. Occupational Safety and Benefit Authority of Chemical Industry. Safe Biotechnology: Classification of Biological Agents—Viruses. Guidelines B 004 9/90.
14. Occupational Safety and Health Administration. 1991. Occupational Exposures to Bloodborne Pathogens, final rule. Fed. Regist. 56: 64175– 64182.
15. Office of Laboratory Security, Health Canada. 2004. Laboratory Biosafety Guidelines, 3rd ed. Office of Laboratory Security, Health Canada, Ontario, Canada.
16. Standards Australia/Standards New Zealand. 2002. Safety in Laboratories. Part 3: Microbiological Aspects and Containment Facilities. Australia/New Zealand Standard. AS/NZS 2243.3:2002. Standards Australia International Ltd., Sydney, Australia.
17. World Health Organization. 1991. Biosafety Guidelines for Diagnostic and Research Laboratories Working with HIV. WHO AIDS Series, No. 9. World Health Organization, Geneva, Switzerland.
18. World Health Organization. 2004. Laboratory Biosafety Manual, 3rd ed. World Health Organization, Geneva, Switzerland.
19. World Health Organization. 1997. Guidelines for the Safe Transport of Infectious Substances and Diagnostic Specimens. Division of Emerging and Other Communicable Surveillance and Control. WHO/EMC/97.3. World Health organization, Geneva, Switzerland.

Back to top
This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error